COMPUGEN LTD (CGEN:NASDAQ)
$2.11 -0.02 (-0.939%)
Analysed COMPUGEN LTD (CGEN:NASDAQ) News Sources
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development Conference
06-10-2026
yahoo.com
Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development
08-06-2026
yahoo.com
Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
11-06-2026
yahoo.com
Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026
20-07-2026
yahoo.com
Compugen to Participate in BTIG Biotechnology Conference 2026
21-07-2026
yahoo.com
Compugen Reports Second Quarter 2026 Results
03-08-2026
yahoo.com
Compugen Q2 Earnings Call Highlights
03-08-2026
marketbeat.com
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancing COM701 with Strong Cash ...
06-08-2026
yahoo.com
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference
08-09-2026
yahoo.com
Compugen Highlights COM701 Ovarian Trial, Expands AI Platform Into Tumor Targets
05-10-2026
marketbeat.com
What is the current price of COMPUGEN LTD (CGEN:NASDAQ)?
The current price of COMPUGEN LTD (CGEN:NASDAQ) is $2.11.
COMPUGEN LTD (CGEN:NASDAQ) absolute price change since previous trading day?
The absolute price change of COMPUGEN LTD (CGEN:NASDAQ) since the previous trading day is $-0.02.
COMPUGEN LTD (CGEN:NASDAQ) percentage price change since previous trading day?
The percentage price change of COMPUGEN LTD (CGEN:NASDAQ) since the previous trading day is -0.939%.
What is the most recent average sentiment score for COMPUGEN LTD (CGEN:NASDAQ)?
The most recent average sentiment score for COMPUGEN LTD (CGEN:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for COMPUGEN LTD (CGEN:NASDAQ)?
The most recent sentiment for COMPUGEN LTD (CGEN:NASDAQ) is .
SEC-8K** Filing Available For COMPUGEN LTD (CGEN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.